Skip to content

A clinical trial on the safety and effectiveness of 5G remote robot-assisted surgery was completed using the thoracic endoscopic surgery system

A clinical trial on the safety and effectiveness of 5G remote robot-assisted surgery was completed using the thoracic endoscopic surgery system - Preliminary study on 5G remote robot assisted thoracoscopic surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500096979
Enrollment
Unknown
Registered
2025-02-10
Start date
2025-02-10
Completion date
Unknown
Last updated
2025-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer, lung benign mass, mediastinal mass, etc.

Interventions

Remote robotic surgery team:5G remote robot assisted thoracoscopic surgery

Sponsors

Gansu Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria (1) 18 years old <= age <=80 years old; (2) Endoscopic thoracic surgery with corresponding surgical indications, including but not limited to the following operations: segmental/lobectomy, mediastinal tumor resection; (3) Patients whose physiological condition is acceptable for thoracoscopic surgery; (4) Willing to cooperate with and complete the study follow-up and related tests; (5) The subjects or their agents voluntarily participate in the experiment and sign the informed consent in person.

Exclusion criteria

Exclusion criteria: Exclusion criteria (1) Pregnant or lactating women; (2) The clinical stage of malignant tumor is IV; (3) Patients in need of emergency surgery; (4) Active bleeding, abnormal coagulation function (prothrombin time (PT) or International normalized ratio (INR) is 1.5 times higher than the upper limit of normal) or platelet count < 80×10^9/L; (5) Patients with serious cardiovascular or circulatory diseases who cannot tolerate surgery; (6) Participants in other clinical trials within the last 1 month; (7) Unable to understand the trial requirements, or unable to complete the study follow-up plan; (8) The researcher believes that there are other circumstances that are not suitable for inclusion.

Design outcomes

Primary

MeasureTime frame
Remote surgery success rate;Network transmission evaluation (network signal delay, total delay, packet loss rate);

Secondary

MeasureTime frame
Robot-assisted surgery time;Intraoperative blood loss;Catheter drainage time;Postoperative hospital stay;Postoperative pain score;Evaluation of the operative psychological load of the surgeon;Subjective evaluation of intraoperative experience;Postoperative complication;Device failure rate;

Countries

China

Contacts

Public ContactYunjiuGou

Gansu Provincial People's Hospital

gouyunjiu@163.com+86 139 1912 7670

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026